4 Analysts Assess Haemonetics: What You Need To Know

By Benzinga Insights

During the last three months, 4 analysts shared their evaluations of Haemonetics (NYSE: HAE ), revealing diverse outlooks from bullish to bearish.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing senti

You are viewing a robot-friendly page.Click hereto reload in standard format.